CryoLab - Cryogenic spray, cutaneous
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
17-01-2022
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Emergo Asia Pacific Pty Ltd T/a Emergo Australia
Class:
Class IIa
Manufactured by:
CryoConcepts LP 1100 Conroy Place, Easton, PA, 18040 United States Of America
Therapeutic area:
44724 - Cryogenic spray, cutaneous
Therapeutic indications:
This device is intended for the surgical destruction of target tissue by applying cryogenic gases at extreme low temperatures. Below are examples of the types of lesions that can be treated: Molluscum Contagiosum Skin Tags Actinic Keratosis Lentigo Verruca Plana Verruca Vulgaris Verruca Plantaris Genital Lesions Seborrheic Keratosis
Authorization status:
A
Authorization date:
2021-12-12
